[Classical and atypical clinical features in amyotrophic lateral sclerosis]
- PMID: 17128085
[Classical and atypical clinical features in amyotrophic lateral sclerosis]
Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder involving primarily motor neurons in the cerebral cortex, brainstem and spinal cord. In the absence of any biological marker, the diagnosis of ALS is based on clinical analysis, combined with the results of electromyography. Consensus diagnosis criteria (El Escorial criteria) have been developed to define workable and internationally acceptable guidelines for the diagnosis of ALS. A combination of lower and upper motor neuron signs with evidence of spread within a region or to other regions is required. The diagnosis of ALS has been categorized into various levels of certainty depending on the presence of upper motor neuron and lower motor neuron signs together in the same topographical anatomic region (brainstem and cervical, thoracic or lumbosacral spinal cord). Clinical types and patterns of ALS have been defined. The emerging concept of "ALS plus" is characterized by the presence of atypical clinical features, e.g. extrapyramidal signs or dementia, in association with the classical phenotype of ALS. This paper reviews the classical and atypical clinical features of ALS.
Similar articles
-
[Clinical characteristics of amyotrophic lateral sclerosis subsets].Rev Neurol (Paris). 2006 Jun;162 Spec No 2:4S29-4S33. Rev Neurol (Paris). 2006. PMID: 17128087 French.
-
[Differential diagnosis and atypical subsets of amyotrophic lateral sclerosis].Rev Neurol (Paris). 2006 Jun;162 Spec No 2:4S81-4S90. Rev Neurol (Paris). 2006. PMID: 17128093 French.
-
Atypical motor neuron disease and related motor syndromes.Semin Neurol. 2001 Jun;21(2):177-87. doi: 10.1055/s-2001-15263. Semin Neurol. 2001. PMID: 11442326 Review.
-
[What are the clinical criteria of amyotrophic lateral sclerosis by clinical form?].Rev Neurol (Paris). 2006 Jun;162 Spec No 2:4S25-4S28. Rev Neurol (Paris). 2006. PMID: 17128086 French.
-
Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.Neurology. 2009 Jun 2;72(22):1948-52. doi: 10.1212/WNL.0b013e3181a8269b. Neurology. 2009. PMID: 19487653
Cited by
-
Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure.Oncotarget. 2015 Sep 15;6(27):24178-91. doi: 10.18632/oncotarget.4680. Oncotarget. 2015. PMID: 26172304 Free PMC article.
-
TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.Arch Neurol. 2008 Nov;65(11):1481-7. doi: 10.1001/archneur.65.11.1481. Arch Neurol. 2008. PMID: 19001167 Free PMC article.
-
CD 4+ T cells in the pathobiology of neurodegenerative disorders.J Neuroimmunol. 2009 Jun 25;211(1-2):3-15. doi: 10.1016/j.jneuroim.2009.04.006. Epub 2009 May 12. J Neuroimmunol. 2009. PMID: 19439368 Free PMC article. Review.
-
Concentrations of beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration.J Neural Transm (Vienna). 2009 Sep;116(9):1169-78. doi: 10.1007/s00702-009-0271-4. Epub 2009 Aug 1. J Neural Transm (Vienna). 2009. PMID: 19649690
-
Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.Mol Diagn Ther. 2009;13(2):115-25. doi: 10.1007/BF03256320. Mol Diagn Ther. 2009. PMID: 19537846 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous